FDA Plan Seeks Better, Not Burdensome, Data Collection, McClellan Says
FDA Commissioner McClellan's strategic plan for the agency envisions "better," not "burdensome," information collection to inform risk management decisions
You may also be interested in...
FDA plans to unveil a broad patient safety strategy over the next few months that will explain how the agency plans to move away from reliance on voluntary reporting to use of automated systems to collect adverse event and medical errors data
FDA's proposed safety reporting requirements would require reports on "near misses" of medical errors within 15 days
FDA's proposed bar code rule does not require that the lot number or expiration date be encoded on product packaging because it has not been shown to be cost effective